ClinicalTrialsFinder
RecruitingNot ApplicableNCT06650813

Adapting the FACETS Program to Sickle Cell Disease

Adapting the FACETS Fatigue Management Program to Sickle Cell Disease

Sponsor

Versailles Hospital

Enrollment

24 participants

Start Date

Jan 10, 2025

Study Type

INTERVENTIONAL

Conditions

Sickle Cell DiseaseFatigue Symptom

Summary

Adaptation of a fatigue management program combining the principles of cognitive-behavioral therapy and energy conservation strategies (FACETS program) for a population of adult patients with sickle cell disease (Drépa-FACETS program).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Drépa-FACETS Program for people with fatigue symptom and sickle cell disease. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERDrépa-FACETS Program

Drépa-FACETS Program for Sickle Cell Disease

Locations(2)

CHU Grenoble Alpes

Grenoble, France

Hospital Versailles

Le Chesnay, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06650813

Related Trials

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

NCT06612268174 locations

Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors

NCT075991761 location

Uganda Sickle Surveillance Study (US-3)

NCT063018934 locations

Empowering Adolescents and Young Adults With Sickle Cell Disease as Partners in Treatment Decision Making (EMPOWER-AYA)

NCT053839111 location

Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants

NCT039378171 location